Drug Use Investigation for ADOAIR (Fluticasone/Salmeterol)
Status:
Completed
Trial end date:
2011-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this post-marketing surveillance is to detect adverse drug reactions
(particularly clinically significant adverse drug reactions) occurring in clinical settings,
to examine factors likely to affect the safety and efficacy in the Japanese asthma patients
treated with fluticasone propionate and salmeterol xinafoate.
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Fluticasone Fluticasone Propionate, Salmeterol Xinafoate Drug Combination Fluticasone-Salmeterol Drug Combination Salmeterol Xinafoate